Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (381-390 of 610) with videos related to

Pageof 61
Sort By:
Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.
Plos One|August 8, 2015
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic LeukemiaLaura B Ramsey, Laura J Janke, Monique A Payton, et al.
Cancer|June 1, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemiaHiroto Inaba, Harriet C Surprise, Stanley Pounds, et al.
Nature|April 15, 2008
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosCharles G Mullighan, Christopher B Miller, Ina Radtke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemiaJun J Yang, Wendy Landier, Wenjian Yang, et al.
The Lancet. Haematology|September 24, 2016
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysisYin Ting Cheung, Noah D Sabin, Wilburn E Reddick, et al.
Blood|August 15, 2019
Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemiaLaura J Janke, Sara L Van Driest, Mary V Portera, et al.
Blood|December 13, 2012
Genome-wide study of methotrexate clearance replicates SLCO1B1Laura B Ramsey, John C Panetta, Colton Smith, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2013
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustmentsJennifer L Pauley, John C Panetta, Kristine R Crews, et al.
Journal of Cancer Survivorship : Research and Practice|February 28, 2018
Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy onlyWei Liu, Yin Ting Cheung, Heather M Conklin, et al.
Pageof 61

Showing results (381-390 of 610) with videos related to

Sort By:
Pageof 61
Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.
Plos One|August 8, 2015
Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic LeukemiaLaura B Ramsey, Laura J Janke, Monique A Payton, et al.
Cancer|June 1, 2012
Effect of body mass index on the outcome of children with acute myeloid leukemiaHiroto Inaba, Harriet C Surprise, Stanley Pounds, et al.
Nature|April 15, 2008
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosCharles G Mullighan, Christopher B Miller, Ina Radtke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemiaJun J Yang, Wendy Landier, Wenjian Yang, et al.
The Lancet. Haematology|September 24, 2016
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysisYin Ting Cheung, Noah D Sabin, Wilburn E Reddick, et al.
Blood|August 15, 2019
Hypertension is a modifiable risk factor for osteonecrosis in acute lymphoblastic leukemiaLaura J Janke, Sara L Van Driest, Mary V Portera, et al.
Blood|December 13, 2012
Genome-wide study of methotrexate clearance replicates SLCO1B1Laura B Ramsey, John C Panetta, Colton Smith, et al.
Cancer Chemotherapy and Pharmacology|June 14, 2013
Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustmentsJennifer L Pauley, John C Panetta, Kristine R Crews, et al.
Journal of Cancer Survivorship : Research and Practice|February 28, 2018
Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy onlyWei Liu, Yin Ting Cheung, Heather M Conklin, et al.
Pageof 61